Publications
788
Citations
44,760
Est. group size
—
Recurring co-author estimate
Active years
61
Publishing since 1966
John H. Alexander conducts research in cardiovascular medicine, focusing on the treatment and management of conditions such as atrial fibrillation, acute coronary syndromes (heart attacks and related emergencies), and blood clotting disorders. His work includes large clinical trials evaluating blood thinners (anticoagulants), antiplatelet drugs, blood transfusion strategies, and clinical practice guidelines used by cardiologists. This research is largely conducted through multi-center clinical trials and contributes to national treatment guidelines for heart disease.
Publication output has remained fairly steady over the past decade, with some year-to-year fluctuation but no clear long-term increase or decline, averaging around 27 papers per year in the most recent five years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Circulation · 2025
- 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes
Journal of the American College of Cardiology · 2025
- Factor XI inhibitors for the prevention and treatment of venous and arterial thromboembolism
Nature Reviews Cardiology · 2025
- Relation of Low-Density Lipoprotein Cholesterol, High-Sensitivity C-Reactive Protein, and Lipoprotein(a) Each to Future Cardiovascular Events and Death After Acute Coronary Syndrome on High-Intensity Statin Therapy: An Analysis of the Placebo Arm of ODYSSEY OUTCOMES
Circulation · 2025
- Biomarker-Based Model for Prediction of Ischemic Stroke in Patients With Atrial Fibrillation
Journal of the American College of Cardiology · 2025
- Blood Transfusion in Patients With Acute Myocardial Infarction, Anemia, and Heart Failure: Lessons From MINT
Circulation Heart Failure · 2025
- Antithrombotic Therapy to Minimize Total Events After ACS or PCI in Atrial Fibrillation
Journal of the American College of Cardiology · 2025
- Pre-treatment lysis time of plasma-derived fibrin clots and bleeding in patients on oral anticoagulants for atrial fibrillation in the ARISTOTLE trial
European Heart Journal · 2025
- Restrictive or Liberal Blood Transfusion in Patients with Myocardial Infarction and CKD
Journal of the American Society of Nephrology · 2025
- Counterpoint: the design and interpretation of blood transfusion randomized clinical trials
Blood · 2025
- Experimental Investigation on the Residual Shear Behavior of 28-Year-Old Decommissioned Prestressed Concrete Voided Slab Girders
Journal of Bridge Engineering · 2025
- Individualized transfusion decisions to minimize adverse cardiovascular outcomes in patients with acute myocardial infarction and anemia
American Heart Journal · 2025
- Asundexian or Apixaban in Patients With Atrial Fibrillation According to Prior Oral Anticoagulant Use
JAMA Cardiology · 2025
- Posterior left pericardiotomy in cardiac surgery and outcomes: PALACS-EF trial extended follow-up
European Heart Journal · 2025
- Sudden cardiac death in patients with atrial fibrillation: role of heart failure, coronary artery disease and biomarkers - Insights from the ARISTOTLE trial
EP Europace · 2025
- Circulation×53
- Journal of the American College of Cardiology×45
- American Heart Journal×38
- European Heart Journal×35
- JAMA Cardiology×17
- Steven R. Steinhubl
Medicine · Purdue University West Lafayette
- Fnu Raja
Medicine · Indiana University
- Carl Pafford
Medicine · Indiana University
- Mohamed Elnaggar
Medicine · Purdue University West Lafayette
- Benjamin Buck
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile